ArticleFrontiers in oncology2022

Durvalumab After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: Inferior Outcomes and Lack of Health Equity in Hispanic Patients Treated With PACIFIC Protocol (LA1-CLICaP).

Luis E Raez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.